SPY421.97-0.14 -0.03%
DIA338.65-2.11 -0.62%
IXIC14,161.35+121.67 0.87%

Aeglea BioTherapeutics Q1 EPS $(0.28) Up From $(0.57) YoY

Aeglea BioTherapeutics (NASDAQ:AGLE) reported quarterly losses of $(0.28) per share. This is a 50.88 percent increase over losses of $(0.57) per share from the same period last year.

05/10/2021 08:37
Aeglea BioTherapeutics (NASDAQ:AGLE) reported quarterly losses of $(0.28) per share. This is a 50.88 percent increase over losses of $(0.57) per share from the same period last year.